+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Tumor Ablation Market Size, Share & Trends Analysis Report by Technology (Radiofrequency, Microwave), Treatment (Surgical, Laparoscopic), Application (Liver Cancer), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 4621735
The Tumor Ablation Market was valued at USD 1.89 billion in 2024, and is projected to reach USD 4.08 billion by 2030, rising at a CAGR of 13.80%. An increasing incidence of cancer and high demand for effective treatment options are the major factors contributing to market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020, and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported. The growing preference for minimally invasive procedures, attributed to advantages like fast recovery, patient comfort, and shorter turnaround times, is projected to drive demand for advanced tumor ablation techniques.

Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.

Tumor Ablation Market Report Highlights

  • Based on technology, the radiofrequency tumor ablation segment led the market with the largest revenue share of 32.8% in 2024.
  • Based on technology, the percutaneous ablation segment accounted for the largest revenue share in 2024.
  • Based on application, the other segments accounted for the largest market share in 2024. The other segment includes various types of cancer, such as bone metastasis and ENT cancer.
  • North America dominated the tumor ablation market with the largest revenue share of 34.33% in 2024.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Treatment
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Treatment outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Tumor Ablation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising incidence of cancer
3.2.1.2. Technological advancements in ablation devices
3.2.1.3. Increasing per capita income
3.2.1.4. Growing demand of minimally invasive surgeries.
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations & approvals
3.2.2.2. Presence of alternative treatment options
3.3. Tumor Ablation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Tumor Ablation Market: Technology Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Radiofrequency ablation
4.1.2. Microwave ablation
4.1.3. Cryoablation
4.1.4. Irreversible electroporation ablation
4.1.5. HIFU
4.1.6. Other ablation technologies
4.2. Technology Market Share, 2024 & 2030
4.3. Segment Dashboard
4.4. Global Tumor Ablation Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Radiofrequency ablation
4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Microwave Ablation
4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Cryoablation
4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Irreversible electroporation ablation
4.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. HIFU
4.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.6. Other ablation technologies
4.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Tumor Ablation Market: Treatment Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Surgical ablation
5.1.2. Laparoscopic ablation
5.1.3. Percutaneous ablation
5.2. Treatment Market Share, 2024 & 2030
5.3. Segment Dashboard
5.4. Global Tumor Ablation Market by Treatment Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Surgical ablation
5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Laparoscopic ablation
5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Percutaneous ablation
5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Tumor Ablation Market: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Kidney cancer
6.1.2. Liver cancer
6.1.3. Breast cancer
6.1.4. Lung cancer
6.1.5. Prostate cancer
6.1.6. Other cancer
6.2. Application Market Share, 2024 & 2030
6.3. Segment Dashboard
6.4. Global Tumor Ablation Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Kidney cancer
6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
6.5.2. Liver cancer
6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Breast cancer
6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Lung cancer
6.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.5. Prostate cancer
6.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.6. Other cancer
6.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Tumor Ablation Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030
7.5. North America
7.5.1. U.S.
7.5.1.1. U.S. market estimates and forecast, 2018-2030 (USD Million)
7.5.2. Canada
7.5.2.1. Canada market estimates and forecast, 2018-2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. UK market estimates and forecast, 2018-2030 (USD Million)
7.6.2. Germany
7.6.2.1. Germany market estimates and forecast, 2018-2030 (USD Million)
7.6.3. France
7.6.3.1. France market estimates and forecast, 2018-2030 (USD Million)
7.6.4. Italy
7.6.4.1. Italy market estimates and forecast, 2018-2030 (USD Million)
7.6.5. Spain
7.6.5.1. Spain market estimates and forecast, 2018-2030 (USD Million)
7.6.6. Norway
7.6.6.1. Norway market estimates and forecast, 2018-2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Sweden market estimates and forecast, 2018-2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Denmark market estimates and forecast, 2018-2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan market estimates and forecast, 2018-2030 (USD Million)
7.7.2. China
7.7.2.1. China market estimates and forecast, 2018-2030 (USD Million)
7.7.3. India
7.7.3.1. India market estimates and forecast, 2018-2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia market estimates and forecast, 2018-2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea market estimates and forecast, 2018-2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand market estimates and forecast, 2018-2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil market estimates and forecast, 2018-2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Mexico market estimates and forecast, 2018-2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Argentina market estimates and forecast, 2018-2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa market estimates and forecast, 2018-2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE market estimates and forecast, 2018-2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait market estimates and forecast, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2024
8.3.4. Medtronic
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Boston Scientific Corporation
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Johnson & Johnson Service Inc. (Ethicon, Inc.)
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. AngioDynamics
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Bioventus Inc. (Misonix Inc.)
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. EDAP TMS
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Chongqing Haifu Medical Technology Co., Ltd
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Mermaid Medical
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. HealthTronics, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. H.S. Hospital Service S.p.A.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America tumor ablation market, by region, 2018-2030 (USD Million)
Table 3 North America tumor ablation market, by technology, 2018-2030 (USD Million)
Table 4 North America tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 5 North America tumor ablation market, by application, 2018-2030 (USD Million)
Table 6 North America tumor ablation market, by application, 2018-2030 (USD Million)
Table 7 U.S tumor ablation market, by technology, 2018-2030 (USD Million)
Table 8 U.S tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 9 U.S tumor ablation market, by application, 2018-2030 (USD Million)
Table 10 Canada tumor ablation market, by technology, 2018-2030 (USD Million)
Table 11 Canada tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 12 Canada tumor ablation market, by application, 2018-2030 (USD Million)
Table 13 Europe tumor ablation market, by region, 2018-2030 (USD Million)
Table 14 Europe tumor ablation market, by technology, 2018-2030 (USD Million)
Table 15 Europe tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 16 Europe tumor ablation market, by application, 2018-2030 (USD Million)
Table 17 Germany tumor ablation market, by technology, 2018-2030 (USD Million)
Table 18 Germany tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 19 Germany tumor ablation market, by application, 2018-2030 (USD Million)
Table 20 UK tumor ablation market, by technology, 2018-2030 (USD Million)
Table 21 UK tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 22 UK tumor ablation market, by application, 2018-2030 (USD Million)
Table 23 France tumor ablation market, by technology, 2018-2030 (USD Million)
Table 24 France tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 25 France tumor ablation market, by application, 2018-2030 (USD Million)
Table 26 Italy tumor ablation market, by technology, 2018-2030 (USD Million)
Table 27 Italy tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 28 Italy tumor ablation market, by application, 2018-2030 (USD Million)
Table 29 Spain tumor ablation market, by technology, 2018-2030 (USD Million)
Table 30 Spain tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 31 Spain tumor ablation market, by application, 2018-2030 (USD Million)
Table 32 Denmark tumor ablation market, by technology, 2018-2030 (USD Million)
Table 33 Denmark tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 34 Denmark tumor ablation market, by application, 2018-2030 (USD Million)
Table 35 Sweden tumor ablation market, by technology, 2018-2030 (USD Million)
Table 36 Sweden tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 37 Sweden tumor ablation market, by application, 2018-2030 (USD Million)
Table 38 Norway tumor ablation market, by technology, 2018-2030 (USD Million)
Table 39 Norway tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 40 Norway tumor ablation market, by application, 2018-2030 (USD Million)
Table 41 Asia Pacific tumor ablation market, by region, 2018-2030 (USD Million)
Table 42 Asia Pacific tumor ablation market, by technology, 2018-2030 (USD Million)
Table 43 Asia Pacific tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 44 Asia Pacific tumor ablation market, by application, 2018-2030 (USD Million)
Table 45 China tumor ablation market, by technology, 2018-2030 (USD Million)
Table 46 China tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 47 China tumor ablation market, by application, 2018-2030 (USD Million)
Table 48 Japan tumor ablation market, by technology, 2018-2030 (USD Million)
Table 49 Japan tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 50 Japan tumor ablation market, by application, 2018-2030 (USD Million)
Table 51 India tumor ablation market, by technology, 2018-2030 (USD Million)
Table 52 India tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 53 India tumor ablation market, by application, 2018-2030 (USD Million)
Table 54 South Korea tumor ablation market, by technology, 2018-2030 (USD Million)
Table 55 South Korea tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 56 South Korea tumor ablation market, by application, 2018-2030 (USD Million)
Table 57 Australia tumor ablation market, by technology, 2018-2030 (USD Million)
Table 58 Australia tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 59 Australia tumor ablation market, by application, 2018-2030 (USD Million)
Table 60 Thailand tumor ablation market, by technology, 2018-2030 (USD Million)
Table 61 Thailand tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 62 Thailand tumor ablation market, by application, 2018-2030 (USD Million)
Table 63 Latin America tumor ablation market, by technology, 2018-2030 (USD Million)
Table 64 Latin America tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 65 Latin America surgical ablation market, by application, 2018-2030 (USD Million)
Table 66 Latin America laparoscopic ablation market, by application, 2018-2030 (USD Million)
Table 67 Latin America percutaneous ablation market, by application, 2018-2030 (USD Million)
Table 68 Latin America tumor ablation market, by application, 2018-2030 (USD Million)
Table 69 Brazil tumor ablation market, by technology, 2018-2030 (USD Million)
Table 70 Brazil tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 71 Brazil surgical ablation market, by application, 2018-2030 (USD Million)
Table 72 Brazil laparoscopic ablation market, by application, 2018-2030 (USD Million)
Table 73 Brazil percutaneous ablation market, by application, 2018-2030 (USD Million)
Table 74 Brazil tumor ablation market, by application, 2018-2030 (USD Million)
Table 75 Mexico tumor ablation market, by technology, 2018-2030 (USD Million)
Table 76 Mexico tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 77 Mexico surgical ablation market, by application, 2018-2030 (USD Million)
Table 78 Mexico laparoscopic ablation market, by application, 2018-2030 (USD Million)
Table 79 Mexico percutaneous ablation market, by application, 2018-2030 (USD Million)
Table 80 Mexico tumor ablation market, by application, 2018-2030 (USD Million)
Table 81 Argentina tumor ablation market, by technology, 2018-2030 (USD Million)
Table 82 Argentina tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 83 Argentina surgical ablation market, by application, 2018-2030 (USD Million)
Table 84 Argentina laparoscopic ablation market, by application, 2018-2030 (USD Million)
Table 85 Argentina percutaneous ablation market, by application, 2018-2030 (USD Million)
Table 86 Argentina tumor ablation market, by application, 2018-2030 (USD Million)
Table 87 MEA tumor ablation market, by region, 2018-2030 (USD Million)
Table 88 MEA tumor ablation market, by technology, 2018-2030 (USD Million)
Table 89 MEA tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 90 MEA tumor ablation market, by application, 2018-2030 (USD Million)
Table 91 South Africa tumor ablation market, by technology, 2018-2030 (USD Million)
Table 92 South Africa tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 93 South Africa tumor ablation market, by application, 2018-2030 (USD Million)
Table 94 Saudi Arabia tumor ablation market, by technology, 2018-2030 (USD Million)
Table 95 Saudi Arabia tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 96 Saudi Arabia tumor ablation market, by application, 2018-2030 (USD Million)
Table 97 UAE tumor ablation market, by technology, 2018-2030 (USD Million)
Table 98 UAE tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 99 UAE tumor ablation market, by application, 2018-2030 (USD Million)
Table 100 Kuwait tumor ablation market, by technology, 2018-2030 (USD Million)
Table 101 Kuwait tumor ablation market, by treatment, 2018-2030 (USD Million)
Table 102 Kuwait tumor ablation market, by application, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Tumor ablation market: market outlook
Figure 14 Tumor ablation competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Tumor ablation market driver impact
Figure 20 Tumor ablation market restraint impact
Figure 21 Tumor ablation market strategic initiatives analysis
Figure 22 Tumor ablation market: Technology movement analysis
Figure 23 Tumor ablation market: Technology outlook and key takeaways
Figure 24 Radiofrequency ablation market estimates and forecast, 2018-2030
Figure 25 Microwave ablation estimates and forecast, 2018-2030
Figure 26 Cryoablation market estimates and forecast, 2018-2030
Figure 27 Irreversible electroporation ablation estimates and forecast, 2018-2030
Figure 28 HIFU market estimates and forecast, 2018-2030
Figure 29 Others estimates and forecast, 2018-2030
Figure 30 Tumor ablation Market: Treatment Movement Analysis
Figure 31 Tumor ablation market: Treatment outlook and key takeaways
Figure 32 Surgical ablation market estimates and forecast, 2018-2030
Figure 33 Percutaneous ablation market estimates and forecast, 2018-2030
Figure 34 Laparoscopic ablation market estimates and forecast, 2018-2030
Figure 35 Tumor ablation market: application movement analysis
Figure 36 Tumor ablation market: application outlook and key takeaways
Figure 37 Kidney cancer market estimates and forecast, 2018-2030
Figure 38 Liver cancer market estimates and forecast, 2018-2030
Figure 39 Breast cancer market estimates and forecast, 2018-2030
Figure 40 Lung cancer market estimates and forecast, 2018-2030
Figure 41 Prostate cancer market estimates and forecast, 2018-2030
Figure 42 Other market estimates and forecast, 2018-2030
Figure 43 Global tumor ablation market: Regional movement analysis
Figure 44 Global tumor ablation market: Regional outlook and key takeaways
Figure 45 Global tumor ablation market share and leading players
Figure 46 North America market share and leading players
Figure 47 Europe market share and leading players
Figure 48 Asia Pacific market share and leading players
Figure 49 Latin America market share and leading players
Figure 50 Middle East & Africa market share and leading players
Figure 51 North America: SWOT
Figure 52 Europe SWOT
Figure 53 Asia Pacific SWOT
Figure 54 Latin America SWOT
Figure 55 MEA SWOT
Figure 56 North America
Figure 57 North America market estimates and forecast, 2018-2030
Figure 58 US
Figure 59 US market estimates and forecast, 2018-2030
Figure 60 Canada
Figure 61 Canada market estimates and forecast, 2018-2030
Figure 62 Europe
Figure 63 Europe market estimates and forecast, 2018-2030
Figure 64 UK
Figure 65 UK market estimates and forecast, 2018-2030
Figure 66 Germany
Figure 67 Germany market estimates and forecast, 2018-2030
Figure 68 France
Figure 69 France market estimates and forecast, 2018-2030
Figure 70 Italy
Figure 71 Italy market estimates and forecast, 2018-2030
Figure 72 Spain
Figure 73 Spain market estimates and forecast, 2018-2030
Figure 74 Denmark
Figure 75 Denmark market estimates and forecast, 2018-2030
Figure 76 Sweden
Figure 77 Sweden market estimates and forecast, 2018-2030
Figure 78 Norway
Figure 79 Norway market estimates and forecast, 2018-2030
Figure 80 Asia Pacific
Figure 81 Asia Pacific market estimates and forecast, 2018-2030
Figure 82 China
Figure 83 China market estimates and forecast, 2018-2030
Figure 84 Japan
Figure 85 Japan market estimates and forecast, 2018-2030
Figure 86 India
Figure 87 India market estimates and forecast, 2018-2030
Figure 88 Thailand
Figure 89 Thailand market estimates and forecast, 2018-2030
Figure 90 South Korea
Figure 91 South Korea market estimates and forecast, 2018-2030
Figure 92 Australia
Figure 93 Australia market estimates and forecast, 2018-2030
Figure 94 Latin America
Figure 95 Latin America market estimates and forecast, 2018-2030
Figure 96 Brazil
Figure 97 Brazil market estimates and forecast, 2018-2030
Figure 98 Mexico
Figure 99 Mexico market estimates and forecast, 2018-2030
Figure 100 Argentina
Figure 101 Argentina market estimates and forecast, 2018-2030
Figure 102 Middle East and Africa
Figure 103 Middle East and Africa market estimates and forecast, 2018-2030
Figure 104 South Africa
Figure 105 South Africa market estimates and forecast, 2018-2030
Figure 106 Saudi Arabia
Figure 107 Saudi Arabia market estimates and forecast, 2018-2030
Figure 108 UAE
Figure 109 UAE market estimates and forecast, 2018-2030
Figure 110 Kuwait
Figure 111 Kuwait market estimates and forecast, 2018-2030
Figure 112 Market share of key market players - Tumor ablation market

Companies Mentioned

The major companies profiled in this Tumor Ablation market report include:
  • Medtronic plc.
  • Boston Scientific Corporation
  • Johnson & Johnson Service Inc. (Ethicon, Inc.)
  • AngioDynamics
  • Bioventus Inc. (Misonix Inc.)
  • EDAP TMS
  • Chongqing Haifu Medical Technology Co., Ltd
  • Mermaid Medical
  • HealthTronics, Inc.
  • H.S. Hospital Service S.p.A

Methodology

Loading
LOADING...

Table Information